Covered recipient · General Payments record
MARK ANTHONY VERRA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2022
$5,105.12
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,092.15 | 11 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $258.82 | 3 |
| ABBVIE INC. | $248.34 | 2 |
| Horizon Pharma plc | $125.00 | 1 |
| Spark Therapeutics, Inc. | $124.97 | 1 |
| Novo Nordisk AS | $116.80 | 1 |
| Allergan Inc. | $100.20 | 1 |
| Oyster Point Pharma, Inc. | $94.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $123.34 | 06/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892588367 | CMS |
| ABBVIE INC. | $125.00 | 11/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892588369 | CMS |
| Alcon Vision LLC | $13.59 | 01/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 935104119 | CMS |
| Alcon Vision LLC | $125.00 | 06/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 935104277 | CMS |
| Alcon Vision LLC | $120.23 | 08/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 935104321 | CMS |
| Allergan, Inc. | $100.20 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890001967 | CMS |
| Horizon Therapeutics plc | $125.00 | 06/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 937709345 | CMS |
| Novartis Pharmaceuticals Corporation | $23.40 | 12/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894435029 | CMS |
| Novo Nordisk Inc | $116.80 | 05/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899297461 | CMS |
| Oyster Point Pharma, Inc. | $94.62 | 10/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946068601 | CMS |
| Spark Therapeutics, Inc. | $124.97 | 05/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938541479 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.